Skip to main content
TipRanks
Go Ultimate75% OFF

AngioDynamics (ANGO) Drug Pipeline

534 Followers
Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Auryon Atherectomy System, Balloon AngioplastyPeripheral Arterial DiseasesPhase IVRecruitingAuryon Atherectomy System With Standard Balloon Angioplasty Versus Standard Balloon Angioplasty AloneJan 07, 2025
Nanoknife System, Modified Folfirinox RegimenStage Iii Pancreatic CancerPhase IIIActive Not RecruitingA Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic CancerMar 29, 2019―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Angiodynamics, Inc. (ANGO) have in its pipeline
AngioDynamics ANGO is currently developing the following drugs: Auryon Atherectomy System, Balloon Angioplasty, Nanoknife System, Modified Folfirinox Regimen. These drug candidates are in various stages of clinical development as the company works toward FDA approval.